Literature DB >> 29541931

Deletion of pseudorabies virus US2 gene enhances viral titers in a porcine cerebral cortex primary culture system.

Chuang Lyu1, Shuwen Wang1, Mingxia Sun1, Yandong Tang1, Jinmei Peng1, Zhijun Tian1, Xuehui Cai2.   

Abstract

Pseudorabies virus (PRV) is a neurotropic virus with the ability to infect peripheral sensory ganglia. The transport of PRV from the peripheral to the central nervous system can cause lethal encephalitis in young piglets. However, the pathogenicity of PRV in the cerebral cortex remains poorly understood. In the present study, we developed a porcine cerebral cortex primary culture system (PCCS) using cerebral cortex tissue dissected from a 3-day-old piglet to investigate the pathogenicity of wild-type (WT) and US2 deleted (ΔUS2) PRV in the CNS in vitro. Immunofluorescence assays revealed cell bodies and neurites as the cellular locations infected by PRV. Growth kinetic analysis showed a persistent increase in WT and ΔUS2 viral titers in PCCS from 4 to 24 h post infection (hpi), thus indicating that US2 deletion did not disrupt viral growth. However, the mean plaque size was significantly higher in ΔUS2 PRV than in WT PRV in infected Vero cells. The viral titers and DNA levels of ΔUS2 PRV were significantly higher at 8 hpi than at 4 hpi, whereas those of WT showed no significant difference between the two time points in PCCS. Morphological investigation revealed induction of massive amounts of bouton-like swellings (varicosities) along the axon shaft in both WT and ΔUS2 PRV-infected neurons in the PCCS. Our data suggest that PRV US2 gene deletion enhances viral titers in PCCS but does not affect the varicosities induced by the viral infection.

Entities:  

Keywords:  Genotype II; Neuronal pathogenicity; Pseudorabies virus; US2; Varicosities

Mesh:

Substances:

Year:  2018        PMID: 29541931     DOI: 10.1007/s11262-018-1552-5

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  43 in total

1.  The gE and gI homologs from two alphaherpesviruses have conserved and divergent neuroinvasive properties.

Authors:  A C Knapp; P J Husak; L W Enquist
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction.

Authors:  E J Wiertz; D Tortorella; M Bogyo; J Yu; W Mothes; T R Jones; T A Rapoport; H L Ploegh
Journal:  Nature       Date:  1996-12-05       Impact factor: 49.962

3.  A high-temperature passaging attenuated Pseudorabies vaccine protects piglets completely against emerging PRV variant.

Authors:  Chao Liang; Wu Tong; Hao Zheng; Fei Liu; Jiqiang Wu; Guoxin Li; En-Min Zhou; Guangzhi Tong
Journal:  Res Vet Sci       Date:  2017-02-13       Impact factor: 2.534

4.  Characterization of pseudorabies virus mutants expressing carboxy-terminal truncations of gE: evidence for envelope incorporation, virulence, and neurotropism domains.

Authors:  R S Tirabassi; R A Townley; M G Eldridge; L W Enquist
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Circuit-specific coinfection of neurons in the rat central nervous system with two pseudorabies virus recombinants.

Authors:  J S Kim; L W Enquist; J P Card
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

6.  Varicella-zoster virus influences the activities of components and targets of the ERK signalling pathway.

Authors:  Markus Rahaus; Nathalie Desloges; Manfred H Wolff
Journal:  J Gen Virol       Date:  2006-04       Impact factor: 3.891

7.  A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.

Authors:  Moriah L Szpara; Yolanda R Tafuri; Lance Parsons; S Rafi Shamim; Kevin J Verstrepen; Matthieu Legendre; L W Enquist
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

8.  Alpha-herpesvirus glycoprotein D interaction with sensory neurons triggers formation of varicosities that serve as virus exit sites.

Authors:  Nick De Regge; Hans J Nauwynck; Kristin Geenen; Claude Krummenacher; Gary H Cohen; Roselyn J Eisenberg; Thomas C Mettenleiter; Herman W Favoreel
Journal:  J Cell Biol       Date:  2006-07-10       Impact factor: 10.539

9.  Comparison of Pathogenicity-Related Genes in the Current Pseudorabies Virus Outbreak in China.

Authors:  Yan-Dong Tang; Ji-Ting Liu; Tong-Yun Wang; Ming-Xia Sun; Zhi-Jun Tian; Xue-Hui Cai
Journal:  Sci Rep       Date:  2017-08-10       Impact factor: 4.379

10.  Role of Us9 phosphorylation in axonal sorting and anterograde transport of pseudorabies virus.

Authors:  Radomir Kratchmarov; Matthew P Taylor; Lynn W Enquist
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more
  4 in total

1.  The Attenuated Pseudorabies Virus Vaccine Strain Bartha Hyperactivates Plasmacytoid Dendritic Cells by Generating Large Amounts of Cell-Free Virus in Infected Epithelial Cells.

Authors:  Jonas L Delva; Cliff Van Waesberghe; Wim Van Den Broeck; Jochen A Lamote; Nick Vereecke; Sebastiaan Theuns; Liesbeth Couck; Herman W Favoreel
Journal:  J Virol       Date:  2022-05-23       Impact factor: 6.549

2.  Host BAG3 Is Degraded by Pseudorabies Virus pUL56 C-Terminal 181L-185L and Plays a Negative Regulation Role during Viral Lytic Infection.

Authors:  Chuang Lyu; Wei-Dong Li; Shu-Wen Wang; Jin-Mei Peng; Yong-Bo Yang; Zhi-Jun Tian; Xue-Hui Cai
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

3.  Construction and Immunogenicity of a Recombinant Pseudorabies Virus Variant With TK/gI/gE/11k/28k Deletion.

Authors:  Shijun Yan; Baicheng Huang; Xiaofei Bai; Ying Zhou; Linghua Guo; Tongyan Wang; Yihong Shan; Yuzhou Wang; Feifei Tan; Kegong Tian
Journal:  Front Vet Sci       Date:  2022-01-25

4.  Comprehensive evaluation of the safety and immunogenicity of a gene-deleted variant pseudorabies virus attenuated vaccine.

Authors:  Ling Li; Yongfeng Du; Yanbin Zhang; Pengyu Li; Xinyue Liu; Xin Zhang; Jing Li; Tong Zhang; Xin Li; Dong Xiao; Peng Liu; Peng Qi; Jin Xiao
Journal:  Vet Res       Date:  2022-09-22       Impact factor: 3.829

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.